Chemclin Diagnostics 과거 수익 실적
과거 기준 확인 2/6
Chemclin Diagnostics has been growing earnings at an average annual rate of 1.8%, while the Medical Equipment industry saw earnings growing at 6.4% annually. Revenues have been declining at an average rate of 0.8% per year. Chemclin Diagnostics's return on equity is 9.9%, and it has net margins of 31.4%.
주요 정보
1.8%
수익 성장률
-8.3%
EPS 성장률
Medical Equipment 산업 성장 | 16.0% |
매출 성장률 | -0.8% |
자기자본 수익률 | 9.9% |
순이익 | 31.4% |
최근 수익 업데이트 | 30 Sep 2024 |
최근 과거 실적 업데이트
Recent updates
Little Excitement Around Chemclin Diagnostics Co., Ltd.'s (SHSE:688468) Earnings
Sep 28Concerns Surrounding Chemclin Diagnostics' (SHSE:688468) Performance
May 06Little Excitement Around Chemclin Diagnostics Co., Ltd.'s (SHSE:688468) Earnings
Apr 30Chemclin Diagnostics (SHSE:688468) Shareholders Will Want The ROCE Trajectory To Continue
Mar 27수익 및 비용 분석
Chemclin Diagnostics 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.
수익 및 매출 내역
날짜 | 수익 | 수익 | G+A 비용 | R&D 비용 |
---|---|---|---|---|
30 Sep 24 | 444 | 139 | 141 | 67 |
30 Jun 24 | 452 | 147 | 137 | 62 |
31 Mar 24 | 456 | 151 | 139 | 67 |
31 Dec 23 | 445 | 147 | 133 | 65 |
30 Sep 23 | 451 | 155 | 127 | 64 |
30 Jun 23 | 461 | 160 | 133 | 68 |
31 Mar 23 | 445 | 148 | 129 | 67 |
31 Dec 22 | 465 | 153 | 135 | 68 |
30 Sep 22 | 475 | 153 | 136 | 70 |
30 Jun 22 | 457 | 142 | 136 | 68 |
31 Mar 22 | 471 | 144 | 142 | 71 |
31 Dec 21 | 471 | 143 | 143 | 67 |
30 Sep 21 | 478 | 148 | 149 | 59 |
30 Jun 21 | 504 | 156 | 148 | 64 |
31 Mar 21 | 479 | 144 | 139 | 58 |
31 Dec 20 | 418 | 117 | 129 | 54 |
31 Dec 19 | 455 | 141 | 141 | 55 |
31 Dec 18 | 366 | -424 | 633 | 50 |
31 Dec 17 | 319 | -435 | 621 | 31 |
양질의 수익: 688468 has high quality earnings.
이익 마진 증가: 688468's current net profit margins (31.4%) are lower than last year (34.3%).
잉여현금흐름 대 수익 분석
과거 수익 성장 분석
수익추이: 688468 has become profitable over the past 5 years, growing earnings by 1.8% per year.
성장 가속화: 688468's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
수익 대 산업: 688468 had negative earnings growth (-9.9%) over the past year, making it difficult to compare to the Medical Equipment industry average (-8.8%).
자기자본 수익률
높은 ROE: 688468's Return on Equity (9.9%) is considered low.